Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Esophageal Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Accurate Diagnosis of the Invasion Depth in ESCC by a Deep Neural Network Analysis of NBI Endoscopy Data
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas
- Status
- RECRUITING
- Phase
- PHASE1
A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
PPIO-005 The Relationship Between Different Nutritional Pathways and Tumor Outcomes After Minimally Invasive Esophagectomy
- Status
- COMPLETED
- Phase
- N/A
Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esophageal Squamous Cell Cancer
- Status
- RECRUITING
- Phase
- N/A
Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC
- Status
- RECRUITING
- Phase
- PHASE2
PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC
- Status
- RECRUITING
- Phase
- PHASE2
HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective Phase 2 Clinical Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.
- Status
- RECRUITING
- Phase
- N/A